Unlock instant, AI-driven research and patent intelligence for your innovation.

Bifidobacterium lactis nbk-W13 and application thereof

A technology of nbk-w13, Bifidobacterium lactis, applied in the directions of Bifidobacterium, Lactobacillus, application, etc., can solve the problem of rapid decay of viable bacteria, poor stability of Bifidobacterium lactis, and inability to fully exert product efficacy, etc. problems, to achieve the effect of enhancing immunity, non-specific immune function enhancement, strong acid resistance and bile salt resistance

Active Publication Date: 2019-11-15
诺佰克(武汉)生物科技有限公司
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the common Bifidobacterium lactis products on the market are ubiquitous. When the number of viable bacteria is insufficient, the efficacy of the product cannot be fully exerted, and Bifidobacterium lactis has defects such as poor stability and rapid decay of the number of viable bacteria. Therefore, it is urgently needed Development of new strains of Bifidobacterium lactis with multiple functions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bifidobacterium lactis nbk-W13 and application thereof
  • Bifidobacterium lactis nbk-W13 and application thereof
  • Bifidobacterium lactis nbk-W13 and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1 Screening and Identification of Bifidobacterium lactis nbk-W13

[0052] The feces of healthy infants were collected, ground, diluted with sterile normal saline to a suitable gradient, drawn on the modified MRS agar plate using the four-section line method, and anaerobically cultured in an incubator at 30-42°C for 24-48h. A single colony was selected, examined under a microscope, streaked, and further purified to obtain strain nbk-W13.

[0053] Microbiological characteristics and physiological and biochemical characteristics of strain nbk-W13:

[0054] Cell morphology

[0055] experimental project result Cell morphology Rod s Positive Oxidase Negative Catalase Negative

[0056] Physical and chemical experiment results

[0057]

[0058] The 16S rDNA sequence of strain nbk-W13 is shown in SEQ ID NO:1. According to the identification results of microbiology and molecular biology, the strain nbk-W13 was identified ...

Embodiment 2

[0059] Example 2 Preparation of Bifidobacterium lactis nbk-W13 freeze-dried powder

[0060] The preparation method of bifidobacterium lactis nbk-W13 freeze-dried powder comprises the following steps:

[0061] (1) inoculating Bifidobacterium lactis nbk-W13 into the seed medium for activation to obtain a primary seed liquid;

[0062] (2) inoculating the primary seed liquid into the seed medium for anaerobic cultivation for 8-24 hours to obtain the secondary seed liquid;

[0063] (3) inserting the secondary seed liquid into the fermentation medium to carry out high-density fermentation, centrifuging to take the precipitate, and obtaining the bacteria sludge;

[0064] (4) emulsifying embedding after mixing the bacteria slime and the freeze-drying protective agent to obtain an emulsion;

[0065] (5) The obtained emulsion was freeze-dried and pulverized to obtain the freeze-dried powder of Bifidobacterium lactis nbk-W13.

[0066] In terms of mass percentage, the formula of the se...

Embodiment 3

[0070] Example 3 Preparation of Bifidobacterium lactis nbk-W13 inactivated bacteria powder

[0071] In terms of mass percentage, the formula of the seed medium is: 1.5% lactose, 1.8% peptone, 0.5% yeast extract, 0.5% anhydrous sodium acetate, 0.4% ammonium citrate, 0.02% magnesium sulfate, 0.06% manganese sulfate, 0.06 % L-cysteine ​​hydrochloride, 0.1% Tween 80 and the rest of water, pH 6.8;

[0072] In terms of mass percentage, the formula of the fermentation medium is: 2% lactose, 1.3% peptone, 0.5% yeast extract, 0.5% anhydrous sodium acetate, 0.2% ammonium citrate, 0.06% magnesium sulfate, 0.02% manganese sulfate, 0.06 % L-cysteine ​​hydrochloride, 0.1% Tween 80 and balance water, pH 6.4.

[0073] The specific preparation method of bifidobacterium lactis nbk-W13 inactivated bacteria powder is as follows:

[0074] 1) inoculating Bifidobacterium lactis into a test tube containing a seed medium for activation (37°C, 20h) to obtain a first-grade seed liquid;

[0075] 2) Tr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a bifidobacterium lactis nbk-W13 and application thereof. The provided bifidobacterium lactis nbk-W13 has high acid and cholate resistance and can significantly enhance the immunity. When the effect of the bifidobacterium lactis nbk-W13 on mouse intestinal mucosa immunization is researched, it is found that 14 days after immunocompromised model mice and normal mice orally take the bifidobacterium lactis, the specific cellular immune functions, specific humoral immune functions and non-specific immune functions of all the mice are effectively improved. Moreover, inactivated bacteria of the bifidobacterium lactis nbk-W13 also can enhance the immunity. An experiment shows that bifidobacterium lactis nbk-W13 freeze-dried powder and its inactivated powder can enhance theimmunity by regulating the immune organ coefficients, serum cytokine concentrations, antibody concentrations and intestinal antioxidant capacities of the mice.

Description

technical field [0001] The invention relates to a microorganism and its application, in particular to a bifidobacterium lactis nbk-W13 and its application. Background technique [0002] Bifidobacterium lactis is a beneficial bacterium in the human intestinal tract, which has various functions such as regulating intestinal flora, preventing and treating intestinal diseases, and enhancing the body's immunity. At present, the common Bifidobacterium lactis products on the market are ubiquitous. When the number of viable bacteria is insufficient, the efficacy of the product cannot be fully exerted, and Bifidobacterium lactis has defects such as poor stability and rapid decay of the number of viable bacteria. Therefore, it is urgently needed Development of new strains of Bifidobacterium lactis with multiple functions. Contents of the invention [0003] The object of the present invention is to provide a bifidobacterium lactis nbk-W13 capable of enhancing intestinal mucosal immu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N1/20C12N1/04A23C9/123A23C9/13A23L33/135A61K35/745A61P37/04A61P1/00C12R1/01
CPCC12N1/20C12N1/04A23C9/1238A23C9/1234A23C9/1307A23L33/135A61K35/745A61P37/04A61P1/00A23V2002/00C12R2001/01C12N1/205A23V2400/123A23V2400/531A23V2400/249A23V2200/3204
Inventor 张阳何慧玲潘芬湛剑龙杨帆
Owner 诺佰克(武汉)生物科技有限公司